ICAR-NIHSAD transfers technology of H9N2 vaccine for commercial production

DG, ICAR appreciate the efforts of scientists in developing the vaccine for H9N2 virus.

‘Inactivated low pathogenic avian influenza (H9N2) vaccine for chickens’, developed by the scientists of ICAR- National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal was transferred to Globion India, Secunderabad; Venkateshwara Hatcheries, Pune; Indovax, Gurgaon and Hester Biosciences, Ahmedabad, facilitated by Agrinnovate India (AgIn) at the National Agriculture Science Complex (NASC), New Delhi.

Speaking at the occasion of the technology transfer of the H9N2 vaccine for chickens, Himanshu Pathak, Secretary,Department of Agricultural Research (DARE) & Director General, Indian Council of Agricultural Research (ICAR), appreciated the efforts of the ICAR-NIHSAD scientists in the development of the indigenous vaccine for H9N2 virus and commended the Agrinnovate India (AgIn) for the efforts in the transfer of the technology to the industry.

DG, ICAR appreciate the efforts of scientists